Type II immunoblastic lymphadenopathy

The clinical characteristics of this disease are basically similar to those of type I immunoblastic lymphadenopathy, but the prognosis is poor, which can be regarded as a borderline disease of lymphoid tumors, similar to poor immunoproliferative disease. According to pathological and immunological characteristics, it has gradually been clarified that this disease is different from the aforementioned type I immunoblastic lymphadenopathy, and can also be called T-cell lymphoma-like immunoblastic lymphadenopathy.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.

Was this article helpful? Thanks for the feedback. Thanks for the feedback.